Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 21, 2022; 28(7): 693-703
Published online Feb 21, 2022. doi: 10.3748/wjg.v28.i7.693
Published online Feb 21, 2022. doi: 10.3748/wjg.v28.i7.693
Category | Definition | Treatment |
1 | Negative for dysplasia/neoplasia | No treatment |
2 | Indefinite for dysplasia/neoplasia | Follow-up, recheck |
3 | Non-invasive, low-grade dysplasia | Follow-up |
4 | Non-invasive, high-grade dysplasia | Endoscopic resection, surgery |
4.1 | High-grade adenoma/dysplasia | |
4.2 | Non-invasive carcinoma (CIS) | |
4.3 | Suspicious of invasive carcinoma | |
5 | Invasive neoplasia | Surgery (recently ESD) |
5.1 | Intramucosal carcinoma | |
M1 | Mucosa only | |
M2 | Mucosa with preservation of muscularis mucosae | |
M3 | Not further than muscularis mucosae | |
5.2 | Submucosal carcinoma or beyond | |
sm1 | Invasion of muscularis mucosae < 0.5 µm | |
sm2 | Invasion of muscularis mucosae > 0.5 µm |
- Citation: Chiarello MM, Fico V, Pepe G, Tropeano G, Adams NJ, Altieri G, Brisinda G. Early gastric cancer: A challenge in Western countries. World J Gastroenterol 2022; 28(7): 693-703
- URL: https://www.wjgnet.com/1007-9327/full/v28/i7/693.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i7.693